Quantifying the Dosimetric Impact of Proton Range Uncertainties on RBE-Weighted Dose Distributions in Intensity-Modulated Proton Therapy for Bilateral Head and Neck Cancer
Current Oncology · 2024
DOI: 10.3390/curroncol31070272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, 2024. Verfasst von Suresh Rana und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Lynn Cancer Institute, Boca Raton Regional Hospital, Baptist Health South Florida, Boca Raton, FL 33486, USA. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Proton Therapy, Radiotherapy, Intensity-Modulated, Radiotherapy Dosage. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
In current clinical practice, intensity-modulated proton therapy (IMPT) head and neck cancer (HNC) plans are generated using a constant relative biological effectiveness (cRBE) of 1.1. The primary goal of this study was to explore the dosimetric impact of proton range uncertainties on RBE-weighted dose (RWD) distributions using a variable RBE (vRBE) model in the context of bilateral HNC IMPT plans.
Methods
The current study included the computed tomography (CT) datasets of ten bilateral HNC patients who had undergone photon therapy. Each patient’s plan was generated using three IMPT beams to deliver doses to the CTV_High and CTV_Low for doses of 70 Gy(RBE) and 54 Gy(RBE), respectively, in 35 fractions through a simultaneous integrated boost (SIB) technique. Each nominal plan calculated with a cRBE of 1.1 was subjected to the range uncertainties of ±3%. The McNamara vRBE model was used for RWD calculations. For each patient, the differences in dosimetric metrices between the RWD and nominal dose distributions were compared.
Results
The constrictor muscles, oral cavity, parotids, larynx, thyroid, and esophagus showed average differences in mean dose (Dmean) values up to 6.91 Gy(RBE), indicating the impact of proton range uncertainties on RWD distributions. Similarly, the brachial plexus, brain, brainstem, spinal cord, and mandible showed varying degrees of the average differences in maximum dose (Dmax) values (2.78–10.75 Gy(RBE)). The Dmean and Dmax to the CTV from RWD distributions were within ±2% of the dosimetric results in nominal plans.
Conclusion
The consistent trend of higher mean and maximum doses to the OARs with the McNamara vRBE model compared to cRBE model highlighted the need for consideration of proton range uncertainties while evaluating OAR doses in bilateral HNC IMPT plans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Lynn Cancer Institute, Boca Raton Regional Hospital, Baptist Health South Florida, Boca Raton, FL 33486, USA.
- Department of Radiation Oncology, Florida International University, Miami, FL 33199, USA.
- Centre for Medical Radiation Physics (CMRP), University of Wollongong, Wollongong, NSW 2522, Australia.
ORCID-Profile: Suresh Rana, Noufal Manthala Padannayil, Linh Tran, Anatoly B Rosenfeld
Zitieren
APA
Rana, S., Manthala Padannayil, N., Tran, L., Rosenfeld, A. B., Saeed, H., & Kasper, M. (2024). Quantifying the Dosimetric Impact of Proton Range Uncertainties on RBE-Weighted Dose Distributions in Intensity-Modulated Proton Therapy for Bilateral Head and Neck Cancer. Current Oncology. https://doi.org/10.3390/curroncol31070272
Vancouver
Rana S, Manthala Padannayil N, Tran L, Rosenfeld AB, Saeed H, Kasper M. Quantifying the Dosimetric Impact of Proton Range Uncertainties on RBE-Weighted Dose Distributions in Intensity-Modulated Proton Therapy for Bilateral Head and Neck Cancer. Current Oncology. 2024. doi:10.3390/curroncol31070272
BibTeX
@article{Rana2024,
author = {Rana, Suresh and Manthala Padannayil, Noufal and Tran, Linh and Rosenfeld, Anatoly B and Saeed, Hina and Kasper, Michael},
title = {Quantifying the Dosimetric Impact of Proton Range Uncertainties on RBE-Weighted Dose Distributions in Intensity-Modulated Proton Therapy for Bilateral Head and Neck Cancer},
journal = {Current Oncology},
year = {2024},
doi = {10.3390/curroncol31070272}
}
EUVIMED